Skip to content
May 8, 2025
  • Video
  • Image
  • Instagram
  • Facebook
  • Twitter
  • Linkedin
  • Youtube

PhaMed

Pharmaceutical & Medical News

Primary Menu

PhaMed

  • Pharma News
    • Global News
    • Shortages
    • Resolved Shortages
    • Discontinued Drugs
  • Business
    • Global Pharma Biz
    • Marketing & Sales
    • Merger
    • Pharma Companies
  • Industries
    • Machianeries
    • Packaging
  • Biotech
  • Research
  • Regulatory Affairs
    • FDA
  • Events
  • Home
  • Uncategorized
  • OpenAI and the FDA Are Holding Talks About Using AI In Drug Evaluation
  • FDA
  • Uncategorized

OpenAI and the FDA Are Holding Talks About Using AI In Drug Evaluation

May 7, 2025

High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT…

High-ranking OpenAI employees have met with the FDA multiple times in recent weeks to discuss AI and a project called cderGPT…
Read More

About Author

Zoe Schiffer Emily Mullin Will Knight

See author's posts

Post Navigation

Previous Take on This Military-Inspired Bodyweight Workout to Crush Your Quads
Next Eating ultra-processed foods may speed up early signs of Parkinson’s disease

More Stories

  • Uncategorized

Advanced molecular test can improve diagnosis of a genetic form of COPD

May 7, 2025
  • FDA
  • Uncategorized

OpenAI and the FDA are reportedly discussing AI for drug evaluations

May 7, 2025
  • Uncategorized

Targeting epigenetics: New insights into oral cancer progression and treatment

May 7, 2025

Recent Posts

  • Amgen’s Tepezza granted marketing authorisation in the UK
  • iOnctura starts randomised phase 1/2 trial in lung cancer treatment
  • Advanced molecular test can improve diagnosis of a genetic form of COPD
  • OpenAI and the FDA are reportedly discussing AI for drug evaluations
  • Targeting epigenetics: New insights into oral cancer progression and treatment

Categories

  • FDA
  • Newsbeat
  • Pharma News
  • Research
  • Selected News
  • Uncategorized
  • Latest
  • Popular
  • Trending
  • Amgen’s Tepezza granted marketing authorisation in the UK
    • Selected News

    Amgen’s Tepezza granted marketing authorisation in the UK

    May 8, 2025
  • iOnctura starts randomised phase 1/2 trial in lung cancer treatment
    • Selected News

    iOnctura starts randomised phase 1/2 trial in lung cancer treatment

    May 8, 2025
  • Advanced molecular test can improve diagnosis of a genetic form of COPD
    • Uncategorized

    Advanced molecular test can improve diagnosis of a genetic form of COPD

    May 7, 2025
  • OpenAI and the FDA are reportedly discussing AI for drug evaluations
    • FDA
    • Uncategorized

    OpenAI and the FDA are reportedly discussing AI for drug evaluations

    May 7, 2025
  • Targeting epigenetics: New insights into oral cancer progression and treatment
    • Uncategorized

    Targeting epigenetics: New insights into oral cancer progression and treatment

    May 7, 2025
  • Latest Medical News, Clinical Trials, Guidelines
    • Uncategorized

    Latest Medical News, Clinical Trials, Guidelines

    March 9, 2025
  • When should you eat? Before, after—or even while—exercising?
    • Uncategorized

    When should you eat? Before, after—or even while—exercising?

    March 9, 2025
  • Tamale: Customs seize GH¢20.6m worth of Illicit cigarettes and tapentadol tablets
    • Research

    Tamale: Customs seize GH¢20.6m worth of Illicit cigarettes and tapentadol tablets

    March 9, 2025
  • NIH funding cuts will hit red states, rural areas and underserved communities the hardest
    • Uncategorized

    NIH funding cuts will hit red states, rural areas and underserved communities the hardest

    March 9, 2025
  • RFK Jr.’s 180 on Measles: Too Little, Too Late
    • Uncategorized

    RFK Jr.’s 180 on Measles: Too Little, Too Late

    March 9, 2025

Categories

FDA Newsbeat Pharma News Research Selected News Uncategorized

CoverNews Social

  • Instagram
  • Facebook
  • Twitter
  • Linkedin
  • Youtube

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

You may have missed

Amgen’s Tepezza granted marketing authorisation in the UK
  • Selected News

Amgen’s Tepezza granted marketing authorisation in the UK

May 8, 2025
iOnctura starts randomised phase 1/2 trial in lung cancer treatment
  • Selected News

iOnctura starts randomised phase 1/2 trial in lung cancer treatment

May 8, 2025
Advanced molecular test can improve diagnosis of a genetic form of COPD
  • Uncategorized

Advanced molecular test can improve diagnosis of a genetic form of COPD

May 7, 2025
OpenAI and the FDA are reportedly discussing AI for drug evaluations
  • FDA
  • Uncategorized

OpenAI and the FDA are reportedly discussing AI for drug evaluations

May 7, 2025
Targeting epigenetics: New insights into oral cancer progression and treatment
  • Uncategorized

Targeting epigenetics: New insights into oral cancer progression and treatment

May 7, 2025

About PhaMed

We mainly focus on Pharmaceutical News, provided with an elegant design and a broad spectrum. Our news site and automated process of  collecting pharmacy related news, empower you and your business to stay informed about the trends, and to make professional informed decisions for your business.

Recent News

  • Amgen’s Tepezza granted marketing authorisation in the UK
  • iOnctura starts randomised phase 1/2 trial in lung cancer treatment
  • Advanced molecular test can improve diagnosis of a genetic form of COPD
  • OpenAI and the FDA are reportedly discussing AI for drug evaluations

Categories

FDA Newsbeat Pharma News Research Selected News Uncategorized
  • Home
  • Business
  • Health
  • Newsbeat
  • Instagram
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
Copyright © All rights reserved. | CoverNews by AF themes.